Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary behavior modification comprises structured or guided changes to eating patterns, including food selection, meal timing, and context, often involving education, behavioral counseling, and environmental adjustments to promote healthier choices and prevent or treat chronic diseases. It is not a single molecular entity, protein, or receptor, but rather a clinical and behavioral target for intervention programs and public health strategies[1][3]. Approaches may utilize frameworks such as cognitive behavioral therapy, motivational interviewing, or ecological models to influence behaviors at individual and population levels, impacting health outcomes associated with nutrition-related diseases[3][4]. **Note:** "Dietary behavior modification" is not a molecular or pharmacological target and should not be listed as such in a structured biological database. For information on molecular targets regulating dietary behaviors, refer to central nervous system neurotransmitters, neuropeptides, or specific genetic and molecular regulators such as melanocortin-4 receptor (MC4R), neuropeptide Y (NPY), or FTO[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary behavior modification.